1-5 of 5
Viktor Rotbain Curovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on Curovic et al. Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial. Diabetes Care 2023;46:593–601

Free
Viktor Rotbain Curovic, Frederik Persson, Niels Jongs, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2024;47(2):e21
https://doi.org/10.2337/dci23-0046
Published: 19 January 2024
View articletitled, Response to Comment on Curovic et al. Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial. Diabetes Care 2023;46:593–601
Open the PDF for Response to Comment on Curovic et al. Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial. Diabetes Care 2023;46:593–601 in another window
Journal Articles

Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes

Free
Hatice Isik Mizrak, Tine Willum Hansen, Peter Rossing, Viktor Rotbain Curovic, Dorte Vistisen, Hanan Amadid, Christian Stevns Hansen
Journal: Diabetes Care
Diabetes Care 2023;46(11):1997–2003
https://doi.org/10.2337/dc23-0312
Published: 30 August 2023
View articletitled, Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes
Open the PDF for Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes in another window
Journal Articles

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial

Free
Viktor Rotbain Curovic, Niels Jongs, Marjolein Y.A.M. Kroonen, Emilie H. Zobel, Tine W. Hansen, Taha Sen, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2023;46(3):593–601
https://doi.org/10.2337/dc22-1699
Published: 18 January 2023
View articletitled, Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial
Open the PDF for Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial in another window
Journal Articles

Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial

Free
Viktor Rotbain Curovic, Mie Klessen Eickhoff, Teemu Rönkkö, Marie Frimodt-Møller, Tine Willum Hansen, Harald Mischak, Peter Rossing, Tarunveer Singh Ahluwalia, Frederik Persson
Journal: Diabetes Care
Diabetes Care 2022;45(11):2662–2668
https://doi.org/10.2337/dc22-1157
Published: 23 August 2022
View articletitled, Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial
Open the PDF for Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial in another window
Journal Articles

Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes

Free
Viktor Rotbain Curovic, Simone Theilade, Signe A. Winther, Nete Tofte, Jesper Eugen-Olsen, Frederik Persson, Tine W. Hansen, Jørgen Jeppesen, Peter Rossing
Journal: Diabetes Care
Diabetes Care 2019;42(6):1112–1119
https://doi.org/10.2337/dc18-1427
Published: 18 March 2019
View articletitled, Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes
Open the PDF for Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes in another window